Scilex (SCLX) Competitors $0.35 +0.01 (+1.55%) Closing price 02/14/2025 04:00 PM EasternExtended Trading$0.35 0.00 (-1.13%) As of 02/14/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends SCLX vs. CYRX, CRVS, PRME, ATYR, MNPR, TRVI, ALLO, CMPS, KRRO, and OLMAShould you be buying Scilex stock or one of its competitors? The main competitors of Scilex include Cryoport (CYRX), Corvus Pharmaceuticals (CRVS), Prime Medicine (PRME), Atyr PHARMA (ATYR), Monopar Therapeutics (MNPR), Trevi Therapeutics (TRVI), Allogene Therapeutics (ALLO), COMPASS Pathways (CMPS), Korro Bio (KRRO), and Olema Pharmaceuticals (OLMA). These companies are all part of the "pharmaceutical products" industry. Scilex vs. Cryoport Corvus Pharmaceuticals Prime Medicine Atyr PHARMA Monopar Therapeutics Trevi Therapeutics Allogene Therapeutics COMPASS Pathways Korro Bio Olema Pharmaceuticals Cryoport (NASDAQ:CYRX) and Scilex (NASDAQ:SCLX) are both small-cap transportation companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability, valuation, community ranking and media sentiment. Do insiders and institutionals hold more shares of CYRX or SCLX? 92.9% of Cryoport shares are held by institutional investors. Comparatively, 69.7% of Scilex shares are held by institutional investors. 10.1% of Cryoport shares are held by company insiders. Comparatively, 8.7% of Scilex shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Is CYRX or SCLX more profitable? Cryoport has a net margin of -70.08% compared to Scilex's net margin of -159.10%. Scilex's return on equity of 0.00% beat Cryoport's return on equity.Company Net Margins Return on Equity Return on Assets Cryoport-70.08% -13.35% -6.43% Scilex -159.10%N/A -93.65% Does the MarketBeat Community prefer CYRX or SCLX? Cryoport received 232 more outperform votes than Scilex when rated by MarketBeat users. However, 100.00% of users gave Scilex an outperform vote while only 65.15% of users gave Cryoport an outperform vote. CompanyUnderperformOutperformCryoportOutperform Votes24365.15% Underperform Votes13034.85% ScilexOutperform Votes11100.00% Underperform VotesNo Votes Which has better earnings & valuation, CYRX or SCLX? Cryoport has higher revenue and earnings than Scilex. Cryoport is trading at a lower price-to-earnings ratio than Scilex, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCryoport$233.26M1.43-$99.59M-$3.38-1.99Scilex$46.74M1.84-$114.33M-$0.83-0.43 Does the media refer more to CYRX or SCLX? In the previous week, Cryoport had 1 more articles in the media than Scilex. MarketBeat recorded 1 mentions for Cryoport and 0 mentions for Scilex. Cryoport's average media sentiment score of 1.34 beat Scilex's score of 0.00 indicating that Cryoport is being referred to more favorably in the media. Company Overall Sentiment Cryoport Positive Scilex Neutral Do analysts prefer CYRX or SCLX? Cryoport currently has a consensus target price of $12.29, suggesting a potential upside of 82.55%. Scilex has a consensus target price of $14.00, suggesting a potential upside of 3,854.80%. Given Scilex's stronger consensus rating and higher possible upside, analysts clearly believe Scilex is more favorable than Cryoport.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cryoport 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.57Scilex 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk & volatility, CYRX or SCLX? Cryoport has a beta of 1.59, meaning that its stock price is 59% more volatile than the S&P 500. Comparatively, Scilex has a beta of 1.06, meaning that its stock price is 6% more volatile than the S&P 500. SummaryCryoport beats Scilex on 10 of the 17 factors compared between the two stocks. Get Scilex News Delivered to You Automatically Sign up to receive the latest news and ratings for SCLX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SCLX vs. The Competition Export to ExcelMetricScilexBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$86.13M$3.09B$5.76B$9.21BDividend YieldN/A1.67%5.27%3.99%P/E Ratio-0.4345.4825.5919.43Price / Sales1.84297.96469.2576.00Price / CashN/A192.7646.0638.90Price / Book-0.324.057.305.05Net Income-$114.33M-$40.60M$3.19B$222.81M7 Day Performance0.57%3.50%1.69%1.29%1 Month Performance-21.16%4.18%4.12%1.52%1 Year Performance-81.07%-10.55%22.23%16.53% Scilex Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SCLXScilex3.4638 of 5 stars$0.35+1.5%$14.00+3,854.8%-81.1%$86.13M$46.74M-0.4380CYRXCryoport3.0161 of 5 stars$6.82+0.1%$12.29+80.1%-57.1%$337.11M$233.26M-2.021,170Positive NewsCRVSCorvus Pharmaceuticals2.2798 of 5 stars$5.03-3.5%$12.38+146.0%+113.1%$323.23MN/A-5.4130Short Interest ↑PRMEPrime Medicine3.2745 of 5 stars$2.42-2.0%$13.13+442.4%-66.4%$317.41MN/A-1.18234Gap UpATYRAtyr PHARMA2.2555 of 5 stars$3.78-3.2%$19.25+409.9%N/A$316.87M$350,000.00-4.0253Short Interest ↑News CoverageMNPRMonopar Therapeutics1.5813 of 5 stars$51.89+7.1%$43.00-17.1%+2,416.1%$316.53MN/A-26.3410Gap DownTRVITrevi Therapeutics2.7899 of 5 stars$4.06-4.4%$9.31+129.7%+49.1%$311.71MN/A-9.2220Analyst RevisionNews CoveragePositive NewsALLOAllogene Therapeutics2.9593 of 5 stars$1.49-1.7%$9.73+555.4%-57.4%$311.36M$90,000.00-0.95310Gap UpCMPSCOMPASS Pathways1.9496 of 5 stars$4.48+1.6%$33.60+650.0%-56.5%$306.52MN/A-2.04120Analyst RevisionNews CoverageGap UpKRROKorro Bio1.1581 of 5 stars$32.23-6.9%$144.00+346.8%-42.7%$302.00MN/A0.0070OLMAOlema Pharmaceuticals3.2773 of 5 stars$5.16-9.3%$28.75+457.2%-66.8%$295.67MN/A-2.3670Short Interest ↓ Related Companies and Tools Related Companies CYRX Alternatives CRVS Alternatives PRME Alternatives ATYR Alternatives MNPR Alternatives TRVI Alternatives ALLO Alternatives CMPS Alternatives KRRO Alternatives OLMA Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SCLX) was last updated on 2/17/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredTop Picks for Trump’s Pro-Crypto America10,000% Crypto Opportunities in 2025 27 of the brightest minds in crypto share exclusive intel… Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Scilex Holding Please log in to your account or sign up in order to add this asset to your watchlist. Share Scilex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
